| Financial Year |
March 31 2023 |
| Monetary Funds |
285,026,343.19 |
| Held-for-trading Financial Assets |
110,884,401.19 |
| Notes Receivable |
42,380,438.28 |
| Accounts Receivable |
412,720,340.68 |
| Advances to Suppliers |
130,265,781.19 |
| Other Receivables |
33,140,935.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
875,322,023.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,223,110.34 |
| Other Current Assets |
117,355,603.47 |
| Total Current Assets |
2,022,410,706.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
64,776,889.66 |
| Long-term Equity Investment |
839,700,448.73 |
| Investment Properties |
35,912,978.26 |
| Fixed Assetes |
1,905,754,002.99 |
| Under-construction Projects |
108,450,051.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,687,972.67 |
| R&D expenses |
-- |
| Goodwill |
98,094,971.96 |
| Long-Term Deferred and Prepaid Expenses |
4,296,827.43 |
| Deferred Income Tax Assets |
53,941,438.94 |
| Other Non-Current Assets |
4,579,955.03 |
| Sub-Total of Non-Current Assets |
3,386,272,436.36 |
| Total Assets |
5,408,683,142.95 |
| Short-Term Loans |
579,795,337.71 |
| Trading Financial liabilities |
8,184,727.91 |
| Notes Payable |
437,372,605.10 |
| Accounts Payable |
349,554,471.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
66,351,242.71 |
| Taxes Payable |
15,828,929.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,926,984.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,413,592.71 |
| Other Current Liabilities |
8,116,493.81 |
| Sub-Total of Current Liabilities |
1,608,827,569.10 |
| Long-term Loans |
108,997,397.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,535,078.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
263,112,308.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
565,269,556.75 |
| Total Liabilities |
2,174,097,125.85 |
| Paid-In Capital(Or Share Stock) |
633,265,407.00 |
| Capital Surplus |
565,769,040.20 |
| Surplus Reserve |
201,906,027.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,813,698,294.69 |
| Minority Stockholder's Interest |
28,932,855.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,205,653,161.46 |
| Owner's Equity（Stockholder's Equity） |
3,234,586,017.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,408,683,142.95 |
